Literature DB >> 25556945

Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas.

Andrea C Eitelhuber1, Oliver Vosyka2, Daniel Nagel1, Miriam Bognar1, Dido Lenze3, Katja Lammens4, Florian Schlauderer4, Daniela Hlahla1, Karl-Peter Hopfner4, Georg Lenz5, Michael Hummel3, Steven H L Verhelst2, Daniel Krappmann6.   

Abstract

MALT1 paracaspase is activated upon antigen receptor stimulation to promote lymphocyte activation. In addition, deregulated MALT1 protease activity drives survival of distinct lymphomas such as the activated B cell type of diffuse large B cell lymphoma (ABC-DLBCL). Here, we designed fluorophore or biotin-coupled activity based-probes (ABP) that covalently modify the active center of MALT1. MALT1-ABPs are exclusively labeling an active modified full length form of MALT1 upon T cell stimulation. Further, despite the CARMA1 requirement for initial MALT1 activation, the MALT1-ABPs show that protease activity is not confined to the high-molecular CARMA1-BCL10-MALT1 (CBM) complex. Using biotin-coupled ABPs, we developed a robust assay for sensitive and selective detection of active MALT1 in cell lines, primary lymphocytes, and DLBCL tumor biopsies. Taken together, MALT1-ABPs represent powerful chemical tools to measure cellular MALT1 activation, determine efficacy of small molecule inhibitors, and classify lymphomas based on MALT1 activity status.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25556945     DOI: 10.1016/j.chembiol.2014.10.021

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  12 in total

1.  Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.

Authors:  Kathryn A Jacobs; Gwennan André-Grégoire; Clément Maghe; An Thys; Ying Li; Elizabeth Harford-Wright; Kilian Trillet; Tiphaine Douanne; Carolina Alves Nicolau; Jean-Sébastien Frénel; Nicolas Bidère; Julie Gavard
Journal:  EMBO J       Date:  2019-11-27       Impact factor: 11.598

Review 2.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

3.  A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.

Authors:  Scott Lovell; Leran Zhang; Thomas Kryza; Anna Neodo; Nathalie Bock; Elena De Vita; Elizabeth D Williams; Elisabeth Engelsberger; Congyi Xu; Alexander T Bakker; Maria Maneiro; Reiko J Tanaka; Charlotte L Bevan; Judith A Clements; Edward W Tate
Journal:  J Am Chem Soc       Date:  2021-06-04       Impact factor: 16.383

4.  Backbone Assignment of the MALT1 Paracaspase by Solution NMR.

Authors:  Sofia Unnerståle; Michal Nowakowski; Vera Baraznenok; Gun Stenberg; Jimmy Lindberg; Maxim Mayzel; Vladislav Orekhov; Tatiana Agback
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

5.  BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.

Authors:  Thomas Seeholzer; Susanne Kurz; Florian Schlauderer; Simone Woods; Torben Gehring; Simon Widmann; Katja Lammens; Daniel Krappmann
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

6.  Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.

Authors:  Ashleigh Howes; Paul A O'Sullivan; Felix Breyer; Ashavari Ghose; Li Cao; Daniel Krappmann; Anne M Bowcock; Steven C Ley
Journal:  Biochem J       Date:  2016-04-12       Impact factor: 3.857

7.  Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cells.

Authors:  Isabel Meininger; Richard A Griesbach; Desheng Hu; Torben Gehring; Thomas Seeholzer; Arianna Bertossi; Jan Kranich; Andrea Oeckinghaus; Andrea C Eitelhuber; Ute Greczmiel; Andreas Gewies; Marc Schmidt-Supprian; Jürgen Ruland; Thomas Brocker; Vigo Heissmeyer; Florian Heyd; Daniel Krappmann
Journal:  Nat Commun       Date:  2016-04-12       Impact factor: 14.919

Review 8.  Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.

Authors:  Mélanie Juilland; Margot Thome
Journal:  Curr Opin Hematol       Date:  2016-07       Impact factor: 3.284

9.  Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma.

Authors:  Daniel Nagel; Miriam Bognar; Andrea C Eitelhuber; Kerstin Kutzner; Michelle Vincendeau; Daniel Krappmann
Journal:  Oncotarget       Date:  2015-12-08

Review 10.  The paracaspase MALT1: biological function and potential for therapeutic inhibition.

Authors:  Maike Jaworski; Margot Thome
Journal:  Cell Mol Life Sci       Date:  2015-10-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.